Annual report pursuant to Section 13 and 15(d)

Accrued Liabilities and other Long-Term Liabilities - Components of Accrued Expenses and Other Long-Term Liabilities (Detail)

v3.6.0.2
Accrued Liabilities and other Long-Term Liabilities - Components of Accrued Expenses and Other Long-Term Liabilities (Detail) - USD ($)
$ in Thousands
Dec. 31, 2016
Dec. 31, 2015
Accrued expenses:    
Professional fees $ 1,253 $ 382
Salaries, bonuses and related benefits 2,846 2,492
Accrued severance 53 0
Ovamed manufacturing rights - short term component 900 2,007
Research and development 394 303
Dr. Falk Pharma milestone 2,634 2,717
JMC Accrued Cost Of goods Sold 726 0
Lease impairment 128 146
Other 1,148 523
Total accrued expenses 10,082 8,570
Other long-term liabilities:    
Deferred rent and long-term lease abandonment charge 5,014 584
Total other long-term liabilities $ 5,014 $ 584